VIC Group received the national Priority Award for the pelleted antibiotics range

On November 24, the finalists of the national award in the field of advanced industrial and digital technologies "Priority-2022" were awarded. VIC Group became the only winner in the Agribusiness category and won the award for the development and production of pelleted antibacterial drugs.

VIC Group antibiotics in the form of pellets - AMOXYPREM, DOXYPREM, COLIMIXOL, LINKOPREM, TERPENTIAM, FLORIPREM – are effective drugs developed specifically for feed production. These products are mainly used in industrial pig breeding, providing a rational approach to antibiotic therapy.

The pellets are evenly distributed in the feed, which prevents the overdosing or undersupply of the drug by animals during therapy. Pelleted preparations are thermally stable and do not reduce the efficiency of thermal processing of feed during pelletization. Thanks to the unique production technology, the pellets are resistant to other adverse environmental factors. The pelleted antibiotics by VIC Group are easily administrated, convenient to store and transport.

Pelleted medicinal antibacterial agents are produced at the VIC Group plant using high-tech equipment in compliance with European quality standards (EU GMP).

VIC Group has already received the prestigious Priority award for the second time, the other winners being such companies as Gazpromneft, Norilsk Nickel, Atomenergomash, Transmashholding and leading IT companies in Russia.